About

Publications While At HealthPartners

selected publications

Journal Article

A randomized controlled trial using continuous glucose monitoring to guide food choices and diabetes self-care in people with type 2 diabetes not taking insulin. 

Diabetes Technology & Therapeutics. 2025

Automated insulin delivery in adults with type 2 diabetes: a nonrandomized clinical trial. 

JAMA network open. 2025

Patient-reported outcomes improve with a virtual diabetes care model that includes continuous glucose monitoring. 

Telemedicine Journal and e-Health. 2025

Expert panel recommendations for a standardized ambulatory glucose profile report for connected insulin pens. 

Diabetes Technology & Therapeutics. 2024

Increase access, reduce disparities: recommendations for modifying medicaid CGM coverage eligibility criteria. 

Journal of Diabetes Science and Technology. 2024

Comprehensive telehealth model to support diabetes self-management. 

JAMA network open. 2023

Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes. 

Diabetes Technology & Therapeutics. 2022

Comparing patch vs pen bolus insulin delivery in type 2 diabetes using continuous glucose monitoring metrics and profiles. 

Journal of Diabetes Science and Technology. 2022

Real-world evidence supporting Tandem Control-IQ Hybrid Closed-Loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations. 

Diabetes Technology & Therapeutics. 2022

Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. 

JAMA. 2021

Hypoglycemia and glycemic control in older adults with type 1 diabetes: baseline results from the WISDM Study. 

Journal of Diabetes Science and Technology. 2021

Lost in translation: a disconnect between the science and Medicare coverage criteria for continuous subcutaneous insulin infusion. 

Diabetes Technology & Therapeutics. 2021

The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin. 

Diabetes care. 2021

Diabetes telehealth solutions: improving self-management through remote initiation of continuous glucose monitoring. 

Journal of the Endocrine Society. 2020

Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. 

JAMA. 2020

Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial. 

Lancet (London, England). 2019

Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. 

Journal of Clinical Endocrinology and Metabolism. 2019

Implementation of basal-bolus therapy in type 2 diabetes: a randomized controlled trial comparing bolus insulin delivery using an insulin patch with an insulin pen. 

Diabetes Technology & Therapeutics. 2019

Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. 

Annals of Internal Medicine. 2017

Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND Randomized Clinical Trial. 

JAMA. 2017

Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. 

The lancet. Diabetes & endocrinology. 2017

REPLACE-BG: A randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. 

Diabetes care. 2017

Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels. 

Annals of Internal Medicine. 2017

Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes. 

Diabetes care. 2016

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). 

Diabetes Technology & Therapeutics. 2013

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. 

Journal of Diabetes Science and Technology. 2013

Comparison of a novel insulin bolus-patch with pen/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with diabetes: a randomized, crossover, multicenter study. 

Diabetes Technology & Therapeutics. 2011

Conference Poster

Optimizing basal-bolus therapy in T2D—a randomized controlled trial comparing bolus insulin delivery using an insulin patch vs. an insulin pen [poster]

2018

Review

Coverage for continuous glucose monitoring for individuals with type 2 diabetes treated with nonintensive therapies: an evidence-based approach to policymaking [review]. 

Diabetes Technology & Therapeutics. 2023

Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis [meta-analysis]. 

BMJ open diabetes research & care. 2022

What's wrong with this picture? A critical review of current Centers for Medicare & Medicaid Services coverage criteria for continuous glucose monitoring [review]. 

Diabetes Technology & Therapeutics. 2021

Approach to using trend arrows in the freestyle libre flash glucose monitoring systems in adults [review]. 

Journal of the Endocrine Society. 2018

presentations

Presentation

Strategies to improve adherence to insulin FDC in patients with T2D: are you up to speed [presentation], American Association of Diabetes Educators Annual Meeting (AADE17)

Contact

full name

D. F. Kruger

Quick Info

Publications

Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.

Collaboration

Co-author network

Map of science